Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi

Showing results (111-120 of 1,315) with videos related to

Pageof 132
Sort By:
AJNR. American Journal of Neuroradiology|February 14, 2007
Regional assessment of brain atrophy: a novel approach to achieve a more complete picture of tissue damage associated with central nervous system disorders?Massimo Filippi, Federica Agosta, Maria A Rocca
Journal of Magnetic Resonance Imaging : JMRI|December 23, 2021
Editorial for "Amide Proton Transfer MRI Could Be Used to Evaluate the Pathophysiological Status of White Matter Hyperintensities"Raffaello Bonacchi, Maria A Rocca, Massimo Filippi
Expert Review of Clinical Immunology|April 9, 2022
Impact of immunotherapies on COVID-19 outcomes in multiple sclerosis patientsChiara Zanetta, Maria A Rocca, Massimo Filippi
Expert Opinion on Pharmacotherapy|February 18, 2026
BTK inhibitors in multiple sclerosis: emerging evidence and future directionsChiara Zanetta, Maria Assunta Rocca, Massimo Filippi
Expert Review of Neurotherapeutics|December 1, 2018
Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectivesMaria A Rocca, Paolo Preziosa, Massimo Filippi
Expert Review of Neurotherapeutics|July 20, 2005
Glatiramer acetate in multiple sclerosisDomenico M Mezzapesa, Marco Rovaris, Massimo Filippi
Neurology|October 28, 2022
Foreseeing Before Disease Onset: Brain Atrophy Progression in Genetic Frontotemporal DementiaFederica Agosta, Edoardo Gioele Spinelli, Massimo Filippi
Neurology|February 4, 2025
Age Matters in Multiple Sclerosis: Novel Insights Into Disease Progression From Clinical OnsetMaria A Rocca, Paolo Preziosa, Massimo Filippi
Med (New York, N.Y.)|July 12, 2025
Tolebrutinib for non-relapsing secondary progressive multiple sclerosis: a critical therapeutic gapMaria A Rocca, Paolo Preziosa, Massimo Filippi
Current Opinion in Neurology|May 16, 2025
New approaches to lesion assessment in multiple sclerosisPaolo Preziosa, Massimo Filippi, Maria A Rocca
Pageof 132

Showing results (111-120 of 1,315) with videos related to

Sort By:
Pageof 132
AJNR. American Journal of Neuroradiology|February 14, 2007
Regional assessment of brain atrophy: a novel approach to achieve a more complete picture of tissue damage associated with central nervous system disorders?Massimo Filippi, Federica Agosta, Maria A Rocca
Journal of Magnetic Resonance Imaging : JMRI|December 23, 2021
Editorial for "Amide Proton Transfer MRI Could Be Used to Evaluate the Pathophysiological Status of White Matter Hyperintensities"Raffaello Bonacchi, Maria A Rocca, Massimo Filippi
Expert Review of Clinical Immunology|April 9, 2022
Impact of immunotherapies on COVID-19 outcomes in multiple sclerosis patientsChiara Zanetta, Maria A Rocca, Massimo Filippi
Expert Opinion on Pharmacotherapy|February 18, 2026
BTK inhibitors in multiple sclerosis: emerging evidence and future directionsChiara Zanetta, Maria Assunta Rocca, Massimo Filippi
Expert Review of Neurotherapeutics|December 1, 2018
Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectivesMaria A Rocca, Paolo Preziosa, Massimo Filippi
Expert Review of Neurotherapeutics|July 20, 2005
Glatiramer acetate in multiple sclerosisDomenico M Mezzapesa, Marco Rovaris, Massimo Filippi
Neurology|October 28, 2022
Foreseeing Before Disease Onset: Brain Atrophy Progression in Genetic Frontotemporal DementiaFederica Agosta, Edoardo Gioele Spinelli, Massimo Filippi
Neurology|February 4, 2025
Age Matters in Multiple Sclerosis: Novel Insights Into Disease Progression From Clinical OnsetMaria A Rocca, Paolo Preziosa, Massimo Filippi
Med (New York, N.Y.)|July 12, 2025
Tolebrutinib for non-relapsing secondary progressive multiple sclerosis: a critical therapeutic gapMaria A Rocca, Paolo Preziosa, Massimo Filippi
Current Opinion in Neurology|May 16, 2025
New approaches to lesion assessment in multiple sclerosisPaolo Preziosa, Massimo Filippi, Maria A Rocca
Pageof 132